InsiderClue

Every filing, one decision per row.

Transactions

One row for every decision an insider filed. Open-market buying and selling only. Vesting, grants and the shares withheld to pay the tax on them are not decisions.

Views

Save your view. Keep the filter you have built, and get an email when a new filing matches it. A free account does both.

Create an account Sign in
Companies 1/25
DYN
Result 46 decisions over 120 months
Reset filters
Direction ?
Both46 Bought10 Sold36
Sort by ?
Most recent Largest amount Share of holding
Window ?
1 mo 12 mo 120 mo
Plan ?
Any Discretionary Scheduled (10b5-1) Not stated
Minimum amount ?
Any $100K $1M $10M $100M $500M
Share of their own holding ?
What the chief executive holds ?
Company: DYN Plan: Discretionary
Company
Date
Insider
Role
Action ?
Shares
Amount
Of holding
DYN Dyne Therapeutics, Inc.
25 Jun 2026
Lucera Erick
Chief Financial Officer
Sold at will
2,362
$48.11K
1.9%
DYN Dyne Therapeutics, Inc.
8 Jun 2026
Posner Brian S
Director
Bought
2,000
$33.88K
8.9%
DYN Dyne Therapeutics, Inc.
3 Jun 2026
Posner Brian S
Director
Bought
2,500
$43.70K
12.5%
DYN Dyne Therapeutics, Inc.
26 May 2026
Posner Brian S
Director
Bought
2,000
$36.42K
11.1%
DYN Dyne Therapeutics, Inc.
20 May 2026
Posner Brian S
Director
Bought
2,500
$42.80K
16.1%
DYN Dyne Therapeutics, Inc.
30 Mar 2026
Posner Brian S
Director
Bought
2,000
$34.16K
14.8%
DYN Dyne Therapeutics, Inc.
11 Mar 2026
Posner Brian S
Director
Bought
2,000
$38.70K
17.4%
DYN Dyne Therapeutics, Inc.
6 Mar 2026
Posner Brian S
Director
Bought
3,000
$45.18K
35.3%
DYN Dyne Therapeutics, Inc.
14 Jul 2025
Cox John
CEO & President
Bought
100,000
$911.00K
70.3%
DYN Dyne Therapeutics, Inc.
9 Dec 2024
Kersten Dirk
Director indirect
Sold at will
34,437
$1.00M
0.6%
DYN Dyne Therapeutics, Inc.
6 Dec 2024
Kersten Dirk
Director indirect
Sold at will
101,675
$2.98M
1.8%
DYN Dyne Therapeutics, Inc.
5 Dec 2024
Kersten Dirk
Director indirect
Sold at will
3,806
$110.56K
0.1%
DYN Dyne Therapeutics, Inc.
4 Dec 2024
Kersten Dirk
Director indirect
Sold at will
135,039
$3.97M
2.4%
DYN Dyne Therapeutics, Inc.
3 Dec 2024
Kersten Dirk
Director indirect
Sold at will
29,732
$863.71K
0.5%
DYN Dyne Therapeutics, Inc.
2 Dec 2024
Kersten Dirk
Director indirect
Sold at will 2×
81,201
$2.41M
1.4%
DYN Dyne Therapeutics, Inc.
18 Nov 2024
Incerti Carlo
Director
Sold at will
16,500
$474.05K
100%
DYN Dyne Therapeutics, Inc.
14 Nov 2024
Rhodes Jason P
Director indirect
Sold at will 4×
782
$25.88K
4.7%
DYN Dyne Therapeutics, Inc.
6 Sep 2024
Scalzo Richard William
SVP, Head of Finance & Admin.
Sold at will 2×
126,074
$4.05M
55.4%
DYN Dyne Therapeutics, Inc.
4 Sep 2024
Cox John
CEO & President indirect
Bought 8×
32,000
$1.06M
opened
DYN Dyne Therapeutics, Inc.
11 Jun 2024
Beskrovnaya Oxana
Chief Scientific Officer
Sold at will
2,136
$66.94K
1.4%
DYN Dyne Therapeutics, Inc.
11 Jun 2024
McNeill Jonathan
Chief Business Officer
Sold at will
1,823
$57.13K
1.3%
DYN Dyne Therapeutics, Inc.
9 Jan 2024
Kersten Dirk
Director indirect
Bought 2×
1,714,285
$30.00M
36.5%
DYN Dyne Therapeutics, Inc.
11 Dec 2023
Brumm Joshua T
See Remarks
Sold at will
7,585
$81.31K
1.3%
DYN Dyne Therapeutics, Inc.
11 Dec 2023
HIGH SUSANNA GATTI
Chief Operating Officer
Sold at will
1,616
$17.32K
0.9%
DYN Dyne Therapeutics, Inc.
11 Dec 2023
Beskrovnaya Oxana
Chief Scientific Officer
Sold at will
1,467
$15.73K
0.8%
DYN Dyne Therapeutics, Inc.
11 Dec 2023
Scalzo Richard William
See Remarks
Sold at will
1,380
$14.79K
1.1%
DYN Dyne Therapeutics, Inc.
11 Dec 2023
McNeill Jonathan
Chief Business Officer
Sold at will
1,245
$13.35K
0.8%
DYN Dyne Therapeutics, Inc.
2 Nov 2023
HIGH SUSANNA GATTI
Chief Operating Officer
Sold at will
9,939
$73.55K
9.5%
DYN Dyne Therapeutics, Inc.
18 Sep 2023
Brumm Joshua T
See Remarks
Sold at will
12,032
$113.22K
4.9%
DYN Dyne Therapeutics, Inc.
18 Sep 2023
HIGH SUSANNA GATTI
Chief Operating Officer
Sold at will
2,672
$25.14K
2.5%
DYN Dyne Therapeutics, Inc.
18 Sep 2023
Beskrovnaya Oxana
Chief Scientific Officer
Sold at will
1,436
$13.51K
1.7%
DYN Dyne Therapeutics, Inc.
18 Sep 2023
Scalzo Richard William
See Remarks
Sold at will
1,290
$12.14K
3.1%
DYN Dyne Therapeutics, Inc.
18 Sep 2023
McNeill Jonathan
Chief Business Officer
Sold at will
1,261
$11.87K
2.0%
DYN Dyne Therapeutics, Inc.
12 Sep 2023
Brumm Joshua T
See Remarks
Sold at will
7,672
$79.87K
3.0%
DYN Dyne Therapeutics, Inc.
12 Sep 2023
Farwell Wildon
Chief Medical Officer
Sold at will
1,707
$17.77K
1.9%
DYN Dyne Therapeutics, Inc.
12 Sep 2023
HIGH SUSANNA GATTI
Chief Operating Officer
Sold at will
1,635
$17.02K
1.5%
DYN Dyne Therapeutics, Inc.
12 Sep 2023
Beskrovnaya Oxana
Chief Scientific Officer
Sold at will
1,484
$15.45K
1.7%
DYN Dyne Therapeutics, Inc.
12 Sep 2023
Scalzo Richard William
See Remarks
Sold at will
1,397
$14.54K
3.2%
DYN Dyne Therapeutics, Inc.
15 Jun 2023
Scalzo Richard William
See Remarks
Sold at will
10,000
$120.30K
18.7%
DYN Dyne Therapeutics, Inc.
13 Jun 2023
Scalzo Richard William
See Remarks
Sold at will 2×
41,390
$532.88K
43.6%
DYN Dyne Therapeutics, Inc.
13 Jun 2023
Farwell Wildon
Chief Medical Officer
Sold at will
1,698
$21.11K
1.8%
DYN Dyne Therapeutics, Inc.
13 Jun 2023
HIGH SUSANNA GATTI
Chief Operating Officer
Sold at will
1,625
$20.20K
1.5%
DYN Dyne Therapeutics, Inc.
13 Jun 2023
Beskrovnaya Oxana
Chief Scientific Officer
Sold at will
1,475
$18.33K
1.7%
DYN Dyne Therapeutics, Inc.
12 Jun 2023
Brumm Joshua T
See Remarks
Sold at will
187,748
$2.37M
42.6%
DYN Dyne Therapeutics, Inc.
9 Jun 2023
Brumm Joshua T
See Remarks
Sold at will
76,582
$1.02M
22.1%
DYN Dyne Therapeutics, Inc.
8 Jun 2023
Brumm Joshua T
See Remarks
Sold at will 2×
61,000
$806.69K
18.4%
Showing 1–46 of 46.